$Aytu BioScience(AYTU)$ 现在的问题是能不能拿到FDA的approval. 如果FDA不通过，那股价立马跌回到0.5，如果通过，立马上3块。
CEO says if the company gets fast-track approval from the Food and Drug Administration, "The FDA does have a provision whereby products like this and in times like this can go through emergency use authorization and we’ll pursue that angle."